Company Filing History:
Years Active: 2024
Title: Rashi Srivastava: Innovator in Oligodendrocyte Progenitor Cell Compositions
Introduction
Rashi Srivastava is a notable inventor based in Saratoga, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligodendrocyte progenitor cell compositions. His innovative work aims to advance treatments for various neurological conditions.
Latest Patents
Rashi holds a patent for "Oligodendrocyte progenitor cell compositions." This patent includes compositions comprising a population of oligodendrocyte progenitor cells (OPCs) and outlines methods for making and using these compositions. The patent specifies that the population of cells should contain less than 15% undesirable cell types and less than 2% K7 positive cells. Additionally, it highlights the potential of these cells in treating conditions such as stroke, spinal cord injury, and multiple sclerosis.
Career Highlights
Rashi Srivastava is currently associated with Asterias Biotherapeutics, Inc., where he continues to work on groundbreaking research in cell therapy. His expertise in the field has positioned him as a key player in the development of innovative therapeutic solutions.
Collaborations
Rashi collaborates with talented professionals, including Erik Michael Whiteley and Uzma Shoukat-Mumtaz, who contribute to the advancement of their shared research goals.
Conclusion
Rashi Srivastava's work in oligodendrocyte progenitor cell compositions represents a significant advancement in biotechnology. His contributions have the potential to impact the treatment of serious neurological conditions, showcasing the importance of innovation in the medical field.